Cerity Partners’s Usana Health Sciences USNA Stock Holding History

Cerity Partners’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-5,740	Closed	-$456K	–	518
2019 Q2	$456K	Buy	5,740 +1,027	+22%	+$81.4K	0.03%	332
2019 Q1	$395K	Buy	+4,713	New	+$492K	0.03%	368
2017 Q4	–	Sell	-6,467	Closed	-$373K	–	596
2017 Q3	$373K	Buy	6,467 +607	+10%	+$35.9K	0.03%	383
2017 Q2	$376K	Buy	5,860 +1,202	+26%	+$74.1K	0.03%	264
2017 Q1	$268K	Buy	+4,658	New	+$278K	0.02%	364

Other funds holding USNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cerity Partners's USNA Position: Q3 2019 in Review

Cerity Partners sold out of Usana Health Sciences (USNA) in Q3 2019, closing a stake of 5,740 shares — an estimated $456K sold.

Cerity Partners first reported a position in USNA in Q1 2017 and held it in 5 quarters. The position peaked at $456K in Q2 2019. 169 funds tracked by Wall St. Rank hold USNA as of Q3 2019.

Cerity Partners reported no remaining Usana Health Sciences position as of Q3 2019 after selling out during the quarter.
Cerity Partners sold 5,740 Usana Health Sciences shares in Q3 2019, an estimated $456K.
Cerity Partners first reported a position in Usana Health Sciences in Q1 2017 and held it in 5 quarters.
Cerity Partners's Usana Health Sciences position peaked at $456K in Q2 2019.
169 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2019.

Based on Cerity Partners's 13F filing for Q3 2019, filed 30 Oct 2019.